Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
N Engl J Med. 1999.
PMID: 10219066
Clinical Trial.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1999 | 1 |
| 2001 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2024 | 1 |
Search Results
5 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.
N Engl J Med. 1999 Apr 29;340(17):1314-20. doi: 10.1056/NEJM199904293401703.
N Engl J Med. 1999.
PMID: 10219066
Free article.
Clinical Trial.
BACKGROUND: Women with the polycystic ovary syndrome have insulin resistance and hyperinsulinemia, possibly because of a deficiency of a D-chiro-inositol-containing phosphoglycan that mediates the action of insulin. ...CONCLUSIONS: D …
BACKGROUND: Women with the polycystic ovary syndrome have insulin resistance and hyperinsulinemia, possibly because of …
Systematic Review of the roles of Inositol and Vitamin D in improving fertility among patients with Polycystic Ovary Syndrome.
Clin Exp Reprod Med. 2024 Sep;51(3):181-191. doi: 10.5653/cerm.2023.06485. Epub 2024 Apr 11.
Clin Exp Reprod Med. 2024.
PMID: 38599886
Free PMC article.
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder among reproductive-age women. ...The articles suggest that vitamin D and inositol, particularly myo-inositol and D-chiro-inositol, may represent therapeu …
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder among reproductive-age women. ...T …
Inositol Treatment and ART Outcomes in Women with PCOS.
Int J Endocrinol. 2016;2016:1979654. doi: 10.1155/2016/1979654. Epub 2016 Oct 4.
Int J Endocrinol. 2016.
PMID: 27795706
Free PMC article.
Review.
Polycystic ovary syndrome (PCOS) affects 5-10% of women in reproductive age and is characterized by oligo/amenorrhea, androgen excess, insulin resistance, and typical polycystic ovarian morphology. ...Insulin-sensitizing compounds such as inositol, a B …
Polycystic ovary syndrome (PCOS) affects 5-10% of women in reproductive age and is characterized by oligo/amenorrhea, a …
High Doses of D-Chiro-Inositol Alone Induce a PCO-Like Syndrome and Other Alterations in Mouse Ovaries.
Int J Mol Sci. 2021 May 26;22(11):5691. doi: 10.3390/ijms22115691.
Int J Mol Sci. 2021.
PMID: 34073634
Free PMC article.
Administration of 1000-1500 mg/day D-Chiro-Inositol (DCIns) or a combination of Myo-Inositol (MyoIns) and DCIns in their plasma molar ratio (40:1) for three or more months are among recommended treatments for metabolic syndrome and/or Polycys …
Administration of 1000-1500 mg/day D-Chiro-Inositol (DCIns) or a combination of Myo-Inositol (MyoIns) and DCIns in thei …
Use of insulin-sensitizing agents in patients with polycystic ovary syndrome.
Endocr Pract. 2001 Jul-Aug;7(4):279-86. doi: 10.4158/EP.7.4.279.
Endocr Pract. 2001.
PMID: 11497481
Review.
OBJECTIVE: To review the subject of polycystic ovary syndrome and the therapeutic use of insulin-sensitizing agents in patients with this endocrinopathy. ...CONCLUSION: Current evidence suggests that the use of insulin-sensitizing agents in patients with p …
OBJECTIVE: To review the subject of polycystic ovary syndrome and the therapeutic use of insulin-sensitizing agents in …
Cite